AS
Amrik Singh Bawa
About Amrik Singh Bawa
Data last updated:
Amrik Singh Bawa is a Director at Rickul India Private Limited (since 2016), Director at Rickul International Private Limited (since 2017) and Director at Neugen Path Lab Private Limited (since 2022). The companies operate in FMCG, Chemicals and Materials and Healthcare. The largest current company by reported revenue is Rickul India Private Limited at ₹2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Aug 2016 | 2016 | ₹2 Lakh (FY 2025) | Active | |
| Director | 01 Sep 2017 | 2017 | Under Process Of Striking Off | ||
| Director | 31 Mar 2022 | 2022 | Active |
Board colleagues of Amrik Singh Bawa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Seema Jain | 07511525 | Rickul India Private Limited , Rickul International Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amrik Singh Bawa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amrik Singh Bawa
Amrik Singh Bawa currently holds 3 directorships: Rickul India Private Limited (Director, since 04 Aug 2016, revenue ₹2 Lakh (FY 2025)); Rickul International Private Limited (Director, since 01 Sep 2017); Neugen Path Lab Private Limited (Director, since 31 Mar 2022).
Amrik Singh Bawa was first appointed on 04 Aug 2016 as Director at Rickul India Private Limited. The most recent appointment on record is 31 Mar 2022 at Neugen Path Lab Private Limited.
The current boards of Amrik Singh Bawa's companies include Seema Jain (Rickul India Private Limited).